Company Filing History:

41 out of 614

Mitsubishi Chemical Industries Limited

35 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1977-1981

Loading Chart...

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4258192 - N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically (1981-03-24),

2. 4201863 - N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically (1980-05-06),

3. 4173630 - N.sup.2 Arylsulfonyl-L-argininamides and the pharmaceutically acceptable (1979-11-06),

4. 4140681 - N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically (1979-02-20),

5. 4139529 - N.sup.2 -Naphthalenesulfonyl-L-arginine derivatives and the (1979-02-13),

6. 4133880 - N.sup.2 -Substituted-L-arginine derivatives and the pharmaceutically (1979-01-09),

7. 4131673 - N.sup.2 -arylsulfonyl-L-argininamides and the pharmaceutically (1978-12-26),

8. 4125619 - N.sup.2 -naphthalenesulfonyl-L-arginine derivatives and the (1978-11-14),

9. 4125604 - N2-Arylsulfonyl-L-argininamides and the pharmaceutically acceptable (1978-11-14),

10. 4117127 - N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically (1978-09-26),

11. 4108986 - N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically (1978-08-22),

12. 4104392 - N.sup.2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically (1978-08-01),

13. 4101653 - N.sup.2 -arylsulfonyl-argininamides and the pharmaceutically acceptable (1978-07-18),

14. 4097591 - N.sup.2 -arylsulfonyl-L-argininamides and the pharmaceutically (1978-06-27),

15. 4097472 - N.sup.2 -arylsulfonyl-l-argininamides and the pharmaceutically (1978-06-27),

Title: The Innovative Contributions of Akiko Hijikata

Introduction

Akiko Hijikata, based in Kobe, Japan, is a prolific inventor with a remarkable portfolio that includes 41 patents. His work primarily focuses on advancements in pharmaceutical agents, showcasing his dedication to enhancing healthcare and medical treatments.

Latest Patents

Among his latest inventions are the compounds N.sup.2-arylsulfonyl-L-argininamides and their pharmaceutically acceptable salts. These innovative agents have been identified as effective for inhibiting and suppressing thrombosis in mammals, underscoring the potential impact of his research in treating cardiovascular diseases.

Career Highlights

Hijikata has made significant contributions in the chemical industry, notably through his employment at Mitsubishi Chemical Industries Limited. His work there has facilitated advancements in pharmaceutical research and development, advancing both the company's mission and the field at large.

Collaborations

Throughout his career, Akiko Hijikata has collaborated with notable colleagues, including Shosuke Okamoto and Tohru Tezuka. These partnerships have been instrumental in driving innovation and expanding the reach of his pharmaceutical inventions.

Conclusion

In conclusion, Akiko Hijikata stands out as a distinguished inventor whose work in thrombosis inhibition demonstrates the vital role of innovative minds in the pharmaceutical industry. His extensive patent portfolio and collaborative efforts continue to contribute significantly to medical research and advancements in treatment solutions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.